Back to search
Terminal Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Terminal Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Terminal Cancer trials you may qualify forThis is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlima…
The goal of this study is the assess the use of remote monitoring of vital signs using commercially available medical devices in patients with advanced cancer a…
This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx in…
This is a Phase 1/2a, first-in-human, open-label study of JAB-8263, this study has two parts: solid tumor dose escalation and expansion study and hematology tum…
The present study seeks to assess differences in feasibility and acceptability of music therapy played live and listening to a recording thereof at the palliati…
The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on…
The study aims to find out if community health worker (CHW) support will improve palliative care outcomes in African American patients with advanced cancer, by…
The goal of this clinical trial is to evaluate the effects of cannabidiol in patients with end-stage metastatic castration-resistant prostate cancer (mCRPC). T…
The aim of this study is to determine the effect of dignity therapy on the quality of life and depression levels of cancer patients. Methods: The research was…